Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

HealthGrades names Good Samaritan Hospital as One of America’s 50 Best Hospitals in 2010

Good Samaritan Hospital in Los Angeles is named as One of America’s 50 Best Hospitals in 2010 by HealthGrades, Inc., the nation’s leading independent healthcare ratings organization.

24 Feb 2010

BioMedix Vascular Solutions, Howard University Hospital partner to help uninsured PAD patients

BioMedix Vascular Solutions, Inc. announced today that the company has partnered with Howard University Hospital, Department of Surgery to participate in a Community Health Project and Demonstration focused on diagnosing and treating the potentially life-threatening condition called Peripheral Arterial Disease (PAD).

24 Feb 2010

Take 2 To Save 2 campaign: To send life-changing health messages to those who may be at risk for stroke

The American Stroke Association, a division of the American Heart Association, today launched a campaign that provides people an array of life-changing health messages to send to those who may be at risk for stroke.

24 Feb 2010

Joint science advisory issues messages for diabetics at risk for heart disease and stroke

The data are inconclusive on heart risks from a class of blood sugar-lowering drugs called thiazolidinediones (TZDs) such as pioglitazone (Actos) or rosiglitazone (Avandia), but the medications should be used with close monitoring from healthcare providers according to a joint science advisory from the American College of Cardiology and the American Heart Association.

24 Feb 2010

Medical innovation: A real boon for American patients

An article in the Journal Miner recently highlighted the fact that many people are living longer, healthier and more productive lives thanks to medical innovation and research.

24 Feb 2010

A1C lab test can help in combating diabetes

Approximately 57 million Americans are on the brink of diabetes. Yet research tells us that there is much we can do to keep it from progressing to full-blown diabetes. Lab tests can help us get a grip on the disease, says the American Clinical Laboratory Association President Alan Mertz.

24 Feb 2010

Woman's risk of heart disease intensifies during natural menopause: Study

When women hear the word menopause, they often think about hot flashes, hormone shifts and mood swings. But what about heart disease? Studies show a woman's risk of heart disease intensifies drastically around the time of natural menopause, which for most women is around the age of 50.

24 Feb 2010

OUTCOME, REACH Call partner to integrate stroke-telemedicine data into Get With The Guidelines–Stroke program

Outcome Sciences, Inc., the leading provider of patient registries, studies, and technologies for evaluating real-world outcomes, and REACH Call, the leading provider of web-based telemedicine services, today announced a partnership to integrate stroke-telemedicine data into the American Heart Association’s Get With The Guidelines®–Stroke program.

23 Feb 2010

Genentech's Avastin combination Phase III study in advanced stomach cancer does not meet primary endpoint

Genentech, Inc., a wholly owned member of the Roche Group, today announced that a Phase III study (AVAGAST) did not meet its primary endpoint of showing Avastin® (bevacizumab) plus Xeloda® (capecitabine) or 5-FU and cisplatin chemotherapy extended the lives of people with inoperable or advanced stomach (gastric) cancer, compared to chemotherapy alone.

23 Feb 2010

Committee calls for strategies to curb hypertension

Public health officials and health care providers need to step up their efforts to reduce Americans' increasing rates of high blood pressure and better treat those with the condition, which triggers more than one-third of heart attacks and almost half of heart failures in the United States each year, says a new report from the Institute of Medicine.

23 Feb 2010

Acute stroke care and clinical outcomes improve substantially with stroke program

Acute stroke care and clinical outcomes have improved significantly at hospitals participating in the American Heart Association/American Stroke Association's Get With The Guidelines-Stroke program, according to a large study in Circulation: Cardiovascular Quality and Outcomes, a journal of the American Heart Association.

23 Feb 2010

BioSante Pharmaceuticals' ongoing LibiGel Phase III clinical development program: Additional positive data

BioSante Pharmaceuticals, Inc., today announced additional positive safety data in its ongoing LibiGel Phase III clinical development program. For the second time, unblinded data have been reviewed by the independent DMC of the LibiGel Cardiovascular and Breast Cancer Safety Study. Based on this review, the DMC once again unanimously recommended continuation of the study as described in the FDA-agreed LibiGel safety study protocol, with no modifications.

22 Feb 2010

BrainStorm Cell Therapeutics, Hadassah Medical Center sign collaborative agreement for ALS clinical trials

BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, is extremely pleased to announce that it has entered into a collaborative agreement with Hadassah Medical Center to conduct its ALS clinical trials at the Hadassah Ein Kerem Hospital.

22 Feb 2010

PanGenex provides information in response to inquiries about STC

PanGenex Corporation, a global nutraceutical and dietary supplement manufacturer and marketer, today provided information in response to inquiries about Soft Tissue Calcification ("STC") and the Company's products.

22 Feb 2010

ResMed launches S9 sleep apnoea therapy platform in Europe

ResMed, a leading developer, manufacturer, and distributor of sleep and respiratory medical equipment, today introduced its new cutting-edge sleep apnoea therapy platform called the S9 Series in Europe. The S9 Series combines a sleek design with superior functionality and more comfort. Combined climate control and humidification delivers unsurpassed comfort to the patient by controlling both the temperature and humidity that the patient breathes.

From ResMed Corp 22 Feb 2010

New gene locus influencing risk for atrial fibrillation identified

Atrial fibrillation is a cardiac arrhythmia - a chronic irregularity of heartbeat - which affects an estimated 1 million people in Germany. Although the condition is not acutely life-threatening, it does increase the risk of developing more serious illnesses, such as cardiac insufficiency, stroke and dementia. In the third of a series of genomewide asssociation studies, an international team of researchers, led by LMU physician PD Dr. Stefan K--b, now reports the identification of a new gene locus that has a significant influence on risk for atrial fibrillation.

22 Feb 2010

Researchers identify common gene variant associated with atrial fibrillation

An international research team has identified a common gene variant associated with a form of the irregular heartbeat called atrial fibrillation. In their report in the journal Nature Genetics, being published online, the investigators describe finding that variations affecting a protein that may help control the heart's electrical activity appear to increase the risk of what is called lone atrial fibrillation (AF), a type seen in younger individuals with no other form of heart disease.

22 Feb 2010

CAOT releases new resources to promote safety for older drivers

As part of the National Blueprint for Injury Prevention in Older Drivers, the Canadian Association of Occupational Therapists (CAOT) has released some important new resources for drivers, their families and health care professionals. A series of information brochures and website (www.olderdriversafety.ca) promoting older driver safety were unveiled today at a public forum held at Ottawa's Good Companions Senior Centre.

22 Feb 2010

El Tejano Magazine article: Medical innovation and research help many Americans live longer, healthier

An article that recently appeared in El Tejano Magazine highlighted the fact that many Americans are living longer, healthier and more productive lives because of medical innovation and research.

20 Feb 2010

Amgen's Prolia Complete Response submission: FDA classifies and sets PDUFA date

Amgen Inc. today announced that the U.S. Food and Drug Administration (FDA) has evaluated the content of the Company's Complete Response submission for Prolia™ (denosumab) in the treatment of postmenopausal osteoporosis and classified it as a Class 2 resubmission. With the Class 2 designation, the FDA set a corresponding Prescription Drug User Fee Act (PDUFA) action date of July 25, 2010.

20 Feb 2010

Stroke News and Research

Further Reading

HealthGrades names Good Samaritan Hospital as One of America’s 50 Best Hospitals in 2010

BioMedix Vascular Solutions, Howard University Hospital partner to help uninsured PAD patients

Take 2 To Save 2 campaign: To send life-changing health messages to those who may be at risk for stroke

Joint science advisory issues messages for diabetics at risk for heart disease and stroke

Medical innovation: A real boon for American patients

A1C lab test can help in combating diabetes

Woman's risk of heart disease intensifies during natural menopause: Study

OUTCOME, REACH Call partner to integrate stroke-telemedicine data into Get With The Guidelines–Stroke program

Genentech's Avastin combination Phase III study in advanced stomach cancer does not meet primary endpoint

Committee calls for strategies to curb hypertension

Acute stroke care and clinical outcomes improve substantially with stroke program

BioSante Pharmaceuticals' ongoing LibiGel Phase III clinical development program: Additional positive data

BrainStorm Cell Therapeutics, Hadassah Medical Center sign collaborative agreement for ALS clinical trials

PanGenex provides information in response to inquiries about STC

ResMed launches S9 sleep apnoea therapy platform in Europe

New gene locus influencing risk for atrial fibrillation identified

Researchers identify common gene variant associated with atrial fibrillation

CAOT releases new resources to promote safety for older drivers

El Tejano Magazine article: Medical innovation and research help many Americans live longer, healthier

Amgen's Prolia Complete Response submission: FDA classifies and sets PDUFA date

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News